For instance, PD-L1 positivity was based on PD-L1 expression in tumor-infiltrating immune cells in studies with atezolizumab, in a combined score of tumor cells and immune cells in studies with pembrolizumab, and on expression in tumor cells in lung cancer studies [3,4,5]. The gene discussed is CD274; the disease is lung cancer.